6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center
Veterans Affairs · 244-NETWORK CONTRACT OFFICE 4 (36C244)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24427Q0018 in this department, oldest first.
- Oct 8, 2026 · this noticePre-solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
THIS IS NOT A REQUEST FOR COMPETITIVE OFFERS Philadelphia VA Medical Center This is a Pre-Solicitation Notice for the Department of Veterans Affairs, Network Contracting Office (NCO) 4, radiopharmaceuticals and calibration sources for the Nuclear Medicine Department at the Philadelphia VA Medical Center, 3900 Woodland Avenue, Philadelphia, PA 19104. The full solicitation will be posted on the Contract Opportunities website at www.sam.gov on or about October 8th, 2026. The full solicitation will be unrestricted. The North American Industry Classification System (NAICS) for this procurement is 3… (show all)
25412: the size standard is 1000 employees. Potential offerors are responsible for monitoring this site for the release of the solicitation package and any other pertinent information and for downloading their own copy of the solicitation package. Any amendments issued to this solicitation will ONLY be available on this site. Offerors are advised that they are responsible for obtaining all amendments. All questions must be submitted in writing to the Contracting Officer at keri.hester1@va.gov. No telephone inquiries will be accepted. This notice does not obligate the Government to award a contract neither does it obligate the Government to pay for any quotes or proposal preparation costs. The Government is not obligated to issue a solicitation because of this notice. No other information is available until issuance of the solicitation. All interested parties must be registered in System for Award Management (SAM) pursuant to applicable regulations and guidelines prior to award. Registration information can be found at www.sam.gov. The point of contact is Contracting Officer, Keri Hester, email: keri.hester1@va.gov.
Who won similar work
25 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| CARDINAL HEALTH 414, LLC · $CAH | 10 | $17.1M | Oct 2, 2026 |
| EXELAN PHARMACEUTICALS INC | 9 | $14.6M | Feb 12, 2026 |
| JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | 3 | $1.7M | Jan 17, 2025 |
| Novartis Pharmaceuticals Corporation | 1 | $2.0M | Jan 6, 2026 |
| PETNET SOLUTIONS, INC. | 1 | $568K | Apr 14, 2025 |
| PROGENICS PHARMACEUTICALS INC | 1 | $433K | Nov 12, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 2, 2026CARDINAL HEALTH 414, LLC$4.6M6505--Lab Supplies | Radiopharm | New 5 year consolidation Lebanon & Pittsburgh - Illuccix | 595 and 646 | EDA: 10/01/2026 VLD | Status: moved to collaboration, once actionable will be assigned to Chr
- Oct 1, 2026CARDINAL HEALTH 414, LLC$638K6505--Fluorodeoxyglucose (FDG) Radiopharmaceutical
- Sep 2, 2026CARDINAL HEALTH 414, LLC$3.6M6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare System
- Jul 25, 2026CARDINAL HEALTH 414, LLC$3.6M6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare System
- Apr 2, 2026CARDINAL HEALTH 414, LLC$2.7M6505--Intent to Sole Source | Xofigo RA-223 | Brand Name Only 5 YR-Indefinite Delivery/Indefinite Quantity (IDIQ) Multiple Stations (646, 642, 595)
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$1.5M6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$249K6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$1.0M6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$3.4M6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$127K6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
Competitive landscape
For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.